Cover Image

Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies

As lifestyle and diet structure impact our health, non-alcoholic fatty liver disease (NAFLD) is prevalent all over the world. Some phytomedicines containing berberine (BBR) have been extensively used for centuries in Ayurvedic and traditional Chinese medicine. The goal of this systematic review is t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sichen Ren (Author), Xiao Ma (Author), Ruilin Wang (Author), Honghong Liu (Author), Ying Wei (Author), Shizhang Wei (Author), Manyi Jing (Author), Yanling Zhao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Berberine inhibits IFN-γ signaling pathway in DSS-induced ulcerative colitis
by: Tao Yang, et al.
Published: (2022)

Rutaecarpine Ameliorates Ethanol-Induced Gastric Mucosal Injury in Mice by Modulating Genes Related to Inflammation, Oxidative Stress and Apoptosis
by: Sichen Ren, et al.
Published: (2020)

Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism
by: Yuling Tong, et al.
Published: (2021)

UPLC-Q-TOF/MS-Based Serum and Urine Metabonomics Study on the Ameliorative Effects of Palmatine on Helicobacter pylori-Induced Chronic Atrophic Gastritis
by: Xing Chen, et al.
Published: (2020)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
by: Lisheng Chen, et al.
Published: (2021)

Metabolomics Profiles Associated with the Treatment of Zuojin Pill on Patients with Chronic Nonatrophic Gastritis
by: Xiao Ma, et al.
Published: (2022)

Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review
by: Jianxia Wen, et al.
Published: (2020)

Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis
by: Yubing Li, et al.
Published: (2023)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
by: Hu Li, et al.
Published: (2022)

Berberine Attenuates Macrophages Infiltration in Intracranial Aneurysms Potentially Through FAK/Grp78/UPR Axis
by: Kai Quan, et al.
Published: (2018)

Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
by: Xuan He, et al.
Published: (2023)

Mechanism of Hydrophobic Bile Acid-Induced Hepatocyte Injury and Drug Discovery
by: Shizhang Wei, et al.
Published: (2020)

Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice
by: Shizhang Wei, et al.
Published: (2023)

Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases-A Mini Review
by: Xiao Ma, et al.
Published: (2020)

Metabolomics combined with network pharmacology exploration reveals the modulatory properties of Astragali Radix extract in the treatment of liver fibrosis
by: Dan Wang, et al.
Published: (2019)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
by: Maxime Nachit, et al.
Published: (2021)

Mechanism of Wuzhuyu decoction on alcohol-induced gastric ulcers using integrated network analysis and metabolomics
by: Xin Wang, et al.
Published: (2024)

The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
by: Yuan Dong, et al.
Published: (2022)

Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
by: Shizhang Wei, et al.
Published: (2020)

Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms
by: Lisheng Chen, et al.
Published: (2023)

Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms
by: Peng-Chong Zhu, et al.
Published: (2023)

Prevalence of non-alcoholic fatty liver disease in postmenopausal woman: systematic review and meta-analysis
by: Xiong Xiao, et al.
Published: (2021)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
by: Yajie Fu, et al.
Published: (2022)

Novel Ultrasonographic Fatty Liver Indicator Can Predict Hepatitis in Children With Non-alcoholic Fatty Liver Disease
by: Hsien-Kuan Liu, et al.
Published: (2019)

Association between inflammatory markers and non-alcoholic fatty liver disease in obese children
by: Yamei Duan, et al.
Published: (2022)

Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis
by: Hossein Rafiei, et al.
Published: (2023)

Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
by: Shumin Wei, et al.
Published: (2021)

Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model
by: Bo Chen, et al.
Published: (2020)

Preclinical evidence of reno-protective effect of quercetin on acute kidney injury: a meta-analysis of animal studies
by: Yi-Fan Zeng, et al.
Published: (2023)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
by: Sa Yang, et al.
Published: (2022)

Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis
by: Shuying Xie, et al.
Published: (2023)

Lipophagy and Alcohol-Induced Fatty Liver
by: Li Yang, et al.
Published: (2019)

Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies
by: Shuangyuan Hu, et al.
Published: (2022)

Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK
by: Ying Yang, et al.
Published: (2021)

Clinical Efficacy and Safety of Shashen Maidong Decoction in the Treatment of Pediatric Mycoplasma Pneumonia: A Systematic Review and Meta-Analysis
by: Jiawei Wang, et al.
Published: (2021)

The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway
by: Zhu J, et al.
Published: (2016)

Anticentromere antibody induced by immunization with centromere protein a and Freund's complete adjuvant may interfere with mouse oocyte meiosis
by: Ying Ying, et al.
Published: (2021)

The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review
by: Zhaolin Sun, et al.
Published: (2024)

Platelets in Non-alcoholic Fatty Liver Disease
by: Andrea Dalbeni, et al.
Published: (2022)

NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
by: L.V. Chistova, et al.
Published: (2010)